A novel fluorescent coumarin derivatization reagent, 7-(diethylamino)-2-oxo-2H-chromone-3-carboxylic acid (named as L1), was synthesized by condensation-cyclization and hydrolysis reactions using 4-(diethylamino) salicylaldehyde as the raw material. The derivatization reaction system of L1 and fipronil was established and optimized. The optimal reaction conditions were obtained as follows: condensation catalyst, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride/4-dimethylaminopyridine; reaction solvent, dichloromethane; ratio of L1 to fipronil, 11:1; reaction time, 60 min; and derivatization temperature, 45 ℃. The derivative of fipronil, N-(3-cyano-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-(trifluoromethyl) sulfonyl)-1H-pyrazole-5-yl)-7-(diethylamino)-2-oxo-2H-chromone-3-formamide (named as SF1), was isolated and identified. On this basis, a high performance liquid chromatography-fluorescence detection method (HPLC-FLD) based on pre-column derivatization was established for fipronil determination, with a detection limit of 0.01 μg/L and quantitative limit of 0.036 μg/L. In summary, the HPLC-FLD method presented good sensitivity, accuracy and reliability, and therefore could be applied to the detection of fipronil residue in agricultural products.
- Article type
- Year
- Co-author
Open Access
Issue
Open Access
Issue
The absorption and metabolism of a 1-deoxynojirimycin and hydroxychalcone heterocomplex (DC-5) as a novel potent α-glucosidase inhibitor was investigated in rats. A total of four metabolites derived from DC-5 were identified in the blood of rats gavaged with DC-5 using ultra-performance liquid chromatography quadrupole time-of-flight tandem mass micrometry (UPLC-Q-TOF-MS/MS), including hydrogenated, methylated, sulfonated, and glucuronidated metabolites of DC-5. The concentration of DC-5 in the blood, heart, liver, lung, stomach and small intestine all peaked at 0.5 h after oral administration, while the peak concentration appeared at 1 h in the spleen and kidney. The peak concentration of DC-5 in the blood was 162.76 ng/mL, with a half-life in the terminal phase (T1/2) of 30.66 h and mean residence time (MRT) of 11.41 h. DC-5 was mainly excreted via feces, and a total of 2.26% of the intragastrical DC-5 was found in feces, which was significantly higher than that in urine (0.0156%). The results of pharmacokinetics test showed that the bioavailability of DC-5 in rats was 1.47%.
京公网安备11010802044758号